Vector Science and Therapeutics Corp.
PAIN.V
TSX
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -976.15% | 75.59% | |||
| Total Depreciation and Amortization | 127.27% | 26.92% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 2,048.34% | -207.57% | |||
| Change in Net Operating Assets | 130.53% | -1,150.50% | |||
| Cash from Operations | 29.86% | -38.36% | |||
| Capital Expenditure | -2,670.59% | 97.95% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -707.14% | 90.14% | |||
| Cash from Investing | -1,029.03% | 96.82% | |||
| Total Debt Issued | -200.00% | -125.00% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | 100.00% | |||
| Cash from Financing | 3,453.78% | -134.26% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 126.10% | -43.38% | |||